Pancreatic Cancer Research

ResearcherFox Chase Cancer CenterActive in the last 2 years

Erica A. Golemis

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0003-3618-3673; OpenAlex author ID A5004302234. Sources: OpenAlex.

Their work

Papers
6 (first author 0, last author 2)
Trials
0
Grants
0
Labs led
1
Collaborators
23
Papers, trials and grants by year

2016: 1 paper · 2017: 1 paper · 2018: none · 2019: none · 2020: 1 paper · 2021: 1 paper · 2022: none · 2023: 1 paper · 2024: none · 2025: none · 2026: 1 paper

Papers 6

  1. ANO6-mediated trogocytosis of cancer-associated fibroblasts promotes pancreatic cancer cell growth and immune suppression. Co-author DOI 10.1038/s43018-026-01265-5↗
  2. Intrapancreatic fat, pancreatitis, and pancreatic cancer. Last author DOI 10.1007/s00018-023-04855-z↗
  3. Evaluation of the Small-molecule BRD4 Degrader CFT-2718 in Small-cell Lung Cancer and Pancreatic Cancer Models. Last author DOI 10.1158/1535-7163.mct-20-0831↗
  4. Cholesterol Pathway Inhibition Induces TGF-β Signaling to Promote Basal Differentiation in Pancreatic Cancer. Co-author DOI 10.1016/j.ccell.2020.08.015↗
  5. Targeted delivery of chemotherapy using HSP90 inhibitor drug conjugates is highly active against pancreatic cancer models. Co-author DOI 10.18632/oncotarget.12642↗
  6. Screening of Conditionally Reprogrammed Patient-Derived Carcinoma Cells Identifies ERCC3-MYC Interactions as a Target in Pancreatic Cancer. Co-author DOI 10.1158/1078-0432.ccr-16-0149↗

Closest collaborators

The 23 strongest of 23 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Igor A. Astsaturov · 5 shared papers, 2016–2026 · strength 0.68
  2. Anna C. Lilly · 3 shared papers, 2021–2026 · strength 0.60
  3. Ralph A. Francescone III · 2 shared papers, 2020–2026 · strength 0.26
  4. Charline Ogier · 2 shared papers, 2020–2026 · strength 0.26
  5. Linara Gabitova-Cornell · 2 shared papers, 2020–2026 · strength 0.26
  6. Janusz Franco‐Barraza · 2 shared papers, 2020–2026 · strength 0.26
  7. Edna Cukierman · 2 shared papers, 2020–2026 · strength 0.26
  8. Nathaniel W. Snyder · 1 shared paper, 2026 · strength 0.18
  9. Debora Barbosa Vendramini Costa · 1 shared paper, 2026 · strength 0.18
  10. Tiffany Luong · 1 shared paper, 2026 · strength 0.18
  11. Corinne Bousquet · 1 shared paper, 2026 · strength 0.18
  12. Jerome F. Cros · 1 shared paper, 2026 · strength 0.18
  13. Serge Y Fuchs · 1 shared paper, 2026 · strength 0.18
  14. Rolf A. Brekken · 1 shared paper, 2026 · strength 0.18
  15. Danlin Sun · 1 shared paper, 2021 · strength 0.11
  16. Egor Bobrov · 2 shared papers, 2016–2017 · strength 0.11
  17. Natalya Beglyarova · 2 shared papers, 2016–2017 · strength 0.11
  18. Alana M. O’Reilly · 1 shared paper, 2020 · strength 0.08
  19. Richard A. Moffitt · 1 shared paper, 2020 · strength 0.08
  20. Carolyn Y. Fang · 1 shared paper, 2020 · strength 0.08
  21. Diana Behrens · 1 shared paper, 2016 · strength 0.04
  22. John Parker Hoffman · 1 shared paper, 2016 · strength 0.04
  23. Louis M. Weiner · 1 shared paper, 2016 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.